Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.
2.

RETRACTED: Subcutaneous injections of aluminum at vaccine adjuvant levels activate innate immune genes in mouse brain that are homologous with biomarkers of autism.

Li D, Tomljenovic L, Li Y, Shaw CA.

J Inorg Biochem. 2017 Dec;177:39-54. doi: 10.1016/j.jinorgbio.2017.08.035. Epub 2017 Sep 5. No abstract available. Retraction in: J Inorg Biochem. 2017 Dec;177:247.

3.

Guillian-Barré Syndrome and Acute Disseminated Encephalomyelitis related to the Bivalent Oral Poliovirus Vaccine.

Tomljenovic L.

Isr Med Assoc J. 2016 Oct;18(10):619-622. No abstract available.

4.

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Inbar R, Weiss R, Tomljenovic L, Arango MT, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y.

Immunol Res. 2017 Feb;65(1):136-149. doi: 10.1007/s12026-016-8826-6.

PMID:
27421722
5.

WITHDRAWN: Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Inbar R, Weiss R, Tomljenovic L, Arango MT, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y.

Vaccine. 2016 Jan 9. pii: S0264-410X(16)00016-5. doi: 10.1016/j.vaccine.2015.12.067. [Epub ahead of print]

PMID:
26778424
6.

The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases.

Baker B, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y.

Expert Opin Drug Saf. 2015;14(9):1387-94. doi: 10.1517/14740338.2015.1073710. Epub 2015 Jul 28. Review.

PMID:
26216756
7.

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

Shaw CA, Li D, Tomljenovic L.

Immunotherapy. 2014;6(10):1055-71. doi: 10.2217/imt.14.81. Review.

PMID:
25428645
8.

Aluminum-induced entropy in biological systems: implications for neurological disease.

Shaw CA, Seneff S, Kette SD, Tomljenovic L, Oller JW Jr, Davidson RM.

J Toxicol. 2014;2014:491316. doi: 10.1155/2014/491316. Epub 2014 Oct 2. Review.

9.

Authors' reply: Human papilloma virus vaccine and primary ovarian failure.

Shoenfeld Y, Tomljenovic L.

Am J Reprod Immunol. 2014 Sep;72(3):260-1. doi: 10.1111/aji.12286. Epub 2014 Jul 1. No abstract available.

PMID:
24981881
10.

Authors' reply: Human papillomavirus vaccine and primary ovarian failure.

Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y.

Am J Reprod Immunol. 2014 Apr;71(4):295-6. doi: 10.1111/aji.12200. Epub 2014 Jan 10. No abstract available.

PMID:
24410950
11.

Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the "Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants": Case Report and Literature Review.

Tomljenovic L, Colafrancesco S, Perricone C, Shoenfeld Y.

J Investig Med High Impact Case Rep. 2014 Mar 18;2(1):2324709614527812. doi: 10.1177/2324709614527812. eCollection 2014 Jan-Mar.

12.

Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.

Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y.

Am J Reprod Immunol. 2013 Oct;70(4):309-16. doi: 10.1111/aji.12151. Epub 2013 Jul 31. Review.

PMID:
23902317
13.

Association between vaccination and Guillain-Barré syndrome.

Tomljenovic L, Shoenfeld Y.

Lancet Infect Dis. 2013 Sep;13(9):730-1. doi: 10.1016/S1473-3099(13)70142-7. Epub 2013 Jun 28. No abstract available.

PMID:
23810251
14.

HPV vaccines and cancer prevention, science versus activism.

Tomljenovic L, Wilyman J, Vanamee E, Bark T, Shaw CA.

Infect Agent Cancer. 2013 Feb 1;8(1):6. doi: 10.1186/1750-9378-8-6.

15.

Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil.

Tomljenovic L, Shaw CA.

J Law Med Ethics. 2012 Fall;40(3):673-81. doi: 10.1111/j.1748-720X.2012.00698.x.

PMID:
23061593
16.

Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

Tomljenovic L, Spinosa JP, Shaw CA.

Curr Pharm Des. 2013;19(8):1466-87. Review.

PMID:
23016780
17.

Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety?

Tomljenovic L, Shaw CA.

Am J Public Health. 2012 Sep;102(9):e13-4. doi: 10.2105/AJPH.2012.300837. Epub 2012 Jul 19. No abstract available.

18.

Mandatory HPV vaccination.

Tomljenovic L, Shaw CA.

JAMA. 2012 Jan 18;307(3):254; author reply 254-5. doi: 10.1001/jama.2011.2020. No abstract available.

PMID:
22253388
19.

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Tomljenovic L, Shaw CA.

Ann Med. 2013 Mar;45(2):182-93. doi: 10.3109/07853890.2011.645353. Epub 2011 Dec 22. Review.

PMID:
22188159
20.

"One-size fits all"?

Tomljenovic L, Shaw CA.

Vaccine. 2012 Mar 9;30(12):2040. doi: 10.1016/j.vaccine.2011.11.053. Epub 2011 Nov 23. No abstract available.

PMID:
22119595

Supplemental Content

Loading ...
Support Center